Literature DB >> 28766694

Musicogenic reflex seizures in epilepsy with glutamic acid decarbocylase antibodies.

M Falip1, L Rodriguez-Bel2, S Castañer3, J Miro1, S Jaraba1, J Mora4, J Bas5, M Carreño6.   

Abstract

BACKGROUND: Musicogenic reflex seizures (MRS) are a rare form of seizures described in patients with temporal lobe epilepsy (TLE), mainly of unknown etiology. Epilepsy with antibodies against glutamic acid decarboxylase (GAD-ab) is a form of autoimmune epilepsy for which no specific semiology has been described. AIM OF THE STUDY: To retrospectively review the incidence of MRS in the general epileptic population and in the series of patients with epilepsy and GAD-ab and to describe its clinical and paraclinical characteristics.
METHODS: Patients recorded between January 2010 and January 2016 in the Database of Bellvitge Hospital Epilepsy Unit were reviewed.
RESULTS: From a group of 1510 epileptic patients, three reported MRS (0.0019%) (two patients with epilepsy and GAD-ab and one patient with cryptogenic TLE). The incidence of MRS in patients with epilepsy and GAD-ab was 2 of 22 (9%). Both patients had a normal magnetic resonance Imaging (MRI), but FDG-PET showed medial temporal lobe hypometabolism (unilateral or bilateral) in both and also in the insula in one of them. MRS (recorded via video-EEG[electroencephalography] in one patient) arose from the right temporal lobe.
CONCLUSIONS: MRS may be a distinctive seizure type in patients with epilepsy and antiGADab. Determination of GAD-ab should be carried out in all cases of MRS, even those with normal structural MRI.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  GAD-ab; autoimmune epilepsy; musicogenic seizure; reflex seizure; temporal lobe epilepsy

Mesh:

Substances:

Year:  2017        PMID: 28766694     DOI: 10.1111/ane.12799

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  4 in total

1.  Antibodies Contributing to Focal Epilepsy Signs and Symptoms Score.

Authors:  Anna E M Bastiaansen; Hana Mojzisova; Marienke A A M de Bruijn; Agnes van Sonderen; Roland D Thijs; Marian J M Majoie; Rob P W Rouhl; Marleen H van Coevorden-Hameete; Juna M de Vries; Amaia Muñoz Lopetegi; Bob Roozenbeek; Marco W J Schreurs; Peter A E Sillevis Smitt; Maarten J Titulaer
Journal:  Ann Neurol       Date:  2021-01-27       Impact factor: 10.422

Review 2.  GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions.

Authors:  Popianna Tsiortou; Harry Alexopoulos; Marinos C Dalakas
Journal:  Ther Adv Neurol Disord       Date:  2021-03-30       Impact factor: 6.570

3.  Epileptic seizures and link to memory processes.

Authors:  Ritwik Das; Artur Luczak
Journal:  AIMS Neurosci       Date:  2022-03-07

4.  Hippocampus and Insula Are Targets in Epileptic Patients With Glutamic Acid Decarboxylase Antibodies.

Authors:  Mercè Falip; Laura Rodriguez-Bel; Sara Castañer; Jacint Sala-Padró; Júlia Miro; Sónia Jaraba; Carlos Casasnovas; Francisco Morandeira; Javier Berdejo; Mar Carreño
Journal:  Front Neurol       Date:  2019-01-09       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.